4D-ACS study

The effect of DAPT (dual antiplatelet therapy) in Dosage and Duration on cardiovascular events and bleeding after implantation of DCS (drug coated stent) in ACS patients

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

CRIS

Registry ID

KCT0006992

Enrollment

1128

Registered

2022-02-10

Start date

2021-11-17

Completion date

Unknown

Last updated

2022-03-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Drug : This clinical trial was designed as a prospective, multicenter, randomized, comparative study. In patients who require coronary intervention, coronary intervention and general examination, exam

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: (1) Patients over the age of 19 (2) Patients undergoing intervention for acute coronary syndrome (3) Patients who underwent coronary intervention with a Biofreedom Ultra™ stent

Exclusion criteria

Exclusion criteria: (1) Women of childbearing potential who plan to become pregnant within the study period (2) In case of hypersensitivity to antiplatelet agents or contraindications (3) Patients with a life expectancy of less than 1 year (4) Patients requiring the use of anticoagulants (5) Patients with a previous history of cerebral infarction

Design outcomes

Primary

Measure	Time frame
NACE (Net adverse clinical event), which is defined as a composite of myocardial infarction, reperfusion due to ischemia, cerebral infarction, and BARC (Bleeding Academic Research Consortium) bleeding of 2 or more	—

Secondary

Measure	Time frame
All bleedings	—

Countries

Korea, Republic of

Contacts

Public ContactJeongmi Lee

Gachon University Gil Medical Center

datex79@naver.com+82-32-460-3054

Outcome results